📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Ocrelizumab B cell depletion has no effect on HERV RNA expression in PBMC in MS patients. (2024)

First Author: Tarlinton R

Attributed to: AI gets real: using routine clinical data and Artificial Intelligence to predict worsening of Multiple Sclerosis despite treatment (AIMS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.msard.2024.105597

PubMed Identifier: 38598954

Publication URI: http://europepmc.org/abstract/MED/38598954

Type: Journal Article/Review

Volume: 86

Parent Publication: Multiple sclerosis and related disorders

ISSN: 2211-0348